FDA Inspection 619163 — Aarti Pharmalabs Limited (Custom Synthesis Division)
The FDA completed an inspection of Aarti Pharmalabs Limited (Custom Synthesis Division) on October 1, 2009 in Vapi, Valsad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 1, 2009
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vapi, Valsad (India)